ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1442

$911K Total Retail Price of All Prescriptions

Rank: 27 out of 1442

833 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 11,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CARVEDILOL 776 741 1 8
CRESTOR 628 589 2 10
PLAVIX 475 454 3 14
METOPROLOL SUCCINATE 463 431 4 1
METOPROLOL TARTRATE 460 436 5 6
SIMVASTATIN 451 435 6 2
AMLODIPINE BESYLATE 420 400 7 3
NITROGLYCERIN PATCH 393 379 8 65
HYDROCHLOROTHIAZIDE 370 359 9 16
BENICAR 335 325 10 61
DIOVAN 329 323 11 19
TORSEMIDE 298 295 12 54
PRADAXA 288 278 13 27
LOVAZA 283 269 14 37
COUMADIN 264 257 15 41
ATORVASTATIN CALCIUM 254 235 16 4
BENICAR HCT 251 244 17 86
RANEXA 250 249 18 29
LOSARTAN POTASSIUM 246 232 19 13
FUROSEMIDE 220 203 20 5
CLOPIDOGREL 193 181 21 12
ISOSORBIDE MONONITRATE ER 191 174 22 17
LISINOPRIL 191 180 22 7
NIFEDIPINE ER 179 179 24 39
DOXAZOSIN MESYLATE 170 169 25 69
DIGOXIN 169 158 26 15
MULTAQ 168 168 27 89
LIPITOR 167 159 28 24
ZETIA 150 141 29 31
PRAVASTATIN SODIUM 149 149 30 20
COREG CR 136 136 31 96
DIOVAN HCT 132 128 32 35
VERAPAMIL ER 131 131 33 77
NITROSTAT 131 125 33 44
SPIRONOLACTONE 130 123 35 28
LOSARTAN-HYDROCHLOROTHIAZIDE 127 127 36 30
ATENOLOL 112 107 37 11
DILTIAZEM 24HR CD 104 104 38 59
CLONIDINE HCL 96 95 39 66
BYSTOLIC 95 88 40 32
PROPRANOLOL HCL 84 81 41 116
WARFARIN SODIUM 83 81 42 9
RAMIPRIL 81 81 43 18
ENALAPRIL MALEATE 76 63 44 23
XARELTO 69 69 45 74
CLONIDINE 68 65 46 267
MICARDIS 65 65 47 126
EDARBYCLOR 61 54 10 48 331
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 56 49 52
NISOLDIPINE 53 53 50 218
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.